Meg Finch-Jones

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius et al. · The Lancet · 2008 · 1.9K citations · Full text

Medicine, Oncology, Surgery +17

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius et al. · The Lancet Oncology · 2013 · 1.3K citations

Medicine, Oncology, Surgery +17

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

Richard Fox, Daniel H. Palmer, Hassan Malik et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +9

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial

John Primrose, Stephen Falk, Meg Finch-Jones et al. · The Lancet Oncology · 2014 · 433 citations

Medicine, Oncology, Pharmacotherapy +16

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

John Bridgewater, S. Pugh, Tom Maishman et al. · The Lancet Oncology · 2020 · 239 citations · Full text

Medicine, Oncology, Pharmacotherapy +17